pravastatin has been researched along with Airway Hyper-Responsiveness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, M; Harada, H; Imamura, M; Nakagome, K; Ohtsu, H; Okunishi, K; Tanaka, R; Yamamoto, K | 1 |
| Baker, JR; Fosso, CK; Miller, MJ; Solomon, WR | 1 |
2 other study(ies) available for pravastatin and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung.
Topics: Animals; Antigens; Bronchi; Bronchitis; Bronchoalveolar Lavage Fluid; Down-Regulation; Eosinophils; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunity, Cellular; Immunoglobulins; Interleukin-17; Lymph Nodes; Mice; Mice, Inbred BALB C; Ovalbumin; Pravastatin; Respiratory Hypersensitivity; Spleen | 2009 |
Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia.
Topics: Aged; Eosinophils; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin E; Leukocyte Count; Lovastatin; Male; Pravastatin; Respiratory Hypersensitivity | 1995 |